Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antitumor Activity”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Not Yet RecruitingNCT06652529
What this trial is testing

Phase 1 Dose Escalation and Expansion to Evaluate AROG4-01 in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumors (Phase 1)MesotheliomaColorectal Carcinoma+2 more
Aromics Therapeutics 35
Testing effectiveness (Phase 2)WithdrawnNCT00676871
What this trial is testing

Evaluate the Safety, Tolerability, and Antitumor Activity of Continuous Intravenous Infusion of MEDI-538 in Adults With B-Cell Chronic Lymphocytic Leukemia (CLL)

Who this might be right for
Chronic Lymphocytic Leukemia
MedImmune LLC 30
Early research (Phase 1)Study completedNCT04883957
What this trial is testing

Study of BGB-11417 in Adult Participants With Mature B-cell Malignancies

Who this might be right for
Mature B-cell Malignancies
BeiGene 64
Early research (Phase 1)Looking for participantsNCT07206225
What this trial is testing

Learn About the Study Medicine PF-08052667 in People With Bladder Cancer

Who this might be right for
Non-muscle Invasive Bladder Cancer
Pfizer 294
Early research (Phase 1)Study completedNCT03516123
What this trial is testing

CS3006 in Subjects with Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Solid Tumor, Adult
CStone Pharmaceuticals 18
Early research (Phase 1)Looking for participantsNCT05217693
What this trial is testing

A First-in-human of Multiplle Doses of BB-1705 in Subjects With Locally Advanced/Metastatic Solid Tumors

Who this might be right for
Solid Tumor
Bliss Biopharmaceutical (Hangzhou) Co., Ltd 288
Early research (Phase 1)Looking for participantsNCT07509034
What this trial is testing

Autologous B7-H3 Chimeric Antigen Receptor T Cells in Previously Treated Extensive-Stage Small Cell Lung Cancer With Recurrent or Refractory Disease

Who this might be right for
Extensive-Stage Small Cell Lung CancerExtrapulmonary Neuroendocrine CarcinomaRecurrent or Refractory+1 more
National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)Looking for participantsNCT07610798
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of INV-8989 in Patients With Advanced Solid Tumors Harboring KRAS G12D Mutations

Who this might be right for
Advance Solid TumorsColon and Rectal CancerNon - Small Cell Lung Cancer NSCLC+4 more
Shenzhen Ionova Life Sciences Co., Ltd. 178
Early research (Phase 1)Study completedNCT03811652
What this trial is testing

A Multiple Ascending Dose Study of MEDI7247 in Advanced or Metastatic Solid Tumors

Who this might be right for
Non Small Cell Lung Cancer Squamous (NSCLC-Sq)Head and Neck Squamous Cell Carcinoma (HNSCC)Small Cell Lung Cancer (SCLC)+3 more
MedImmune LLC 8
Early research (Phase 1)Active Not RecruitingNCT06566092
What this trial is testing

Study of Autologous Tumor-Infiltrating Lymphocytes in Pediatric, Adolescent, and Young Adult Participants

Who this might be right for
Soft Tissue SarcomaPrimary Central Nervous System CarcinomaMelanoma+2 more
Iovance Biotherapeutics, Inc. 40
Early research (Phase 1)Looking for participantsNCT05746897
What this trial is testing

A First-in-human, Phase I, Open-label, Multicenter Study of NM1F(Anti-PVRIG) in Patients With Advanced Solid Tumors

Who this might be right for
Ovarian CancerMelanomaTriple Negative Breast Cancer+1 more
Hefei TG ImmunoPharma Co., Ltd. 38
Testing effectiveness (Phase 2)Ended earlyNCT04735575
What this trial is testing

A Ph1/2 Study of EMB-06 in Participants With Relapsed or Refractory Myeloma

Who this might be right for
Relapsed or Refractory Multiple Myeloma
Shanghai EpimAb Biotherapeutics Co., Ltd. 40
Testing effectiveness (Phase 2)Looking for participantsNCT06639256
What this trial is testing

Phase 1/2 Clinical Study of HY07121 Powder for Solution for Infusion in Patients With Advanced Solid Tumors

Who this might be right for
SafetyTolerabilityEfficacy
Sichuan Huiyu Pharmaceutical Co., Ltd 258
Early research (Phase 1)Looking for participantsNCT07510308
What this trial is testing

Clinical Study of MSH2-/- Tumor Cell Vaccines for Advanced pMMR Colorectal Cancer Patients

Who this might be right for
pMMR/MSS Advanced Colorectal Cancer
West China Hospital 9
Early research (Phase 1)Looking for participantsNCT07275073
What this trial is testing

JMT106 Injection in the Treatment of Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorLung Squamous Cell CarcinomaHepatocellular Carcinoma
Shanghai JMT-Bio Inc. 200
Testing effectiveness (Phase 2)Study completedNCT00087984
What this trial is testing

RNA-Loaded Dendritic Cell Cancer Vaccine

Who this might be right for
Renal Cell Carcinoma
Argos Therapeutics 26
Testing effectiveness (Phase 2)Looking for participantsNCT07637448
What this trial is testing

EGFR-TKIs Plus PD-1 in EGFR-Mutant Advanced NSCLC

Who this might be right for
Lung Cancer Non-Small Cell Cancer (NSCLC)EGFR Activating MutationPD-1 Antibody
Nanfang Hospital, Southern Medical University 32
Testing effectiveness (Phase 2)Temporarily pausedNCT05416749
What this trial is testing

A Clinical Study of 8MW2311 in Subjects With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Solid Tumors
Mabwell (Shanghai) Bioscience Co., Ltd. 216
Early research (Phase 1)Looking for participantsNCT06612840
What this trial is testing

GNC-077 in Patients With Locally Advanced or Metastatic Non-small-cell Lung Cancer and Other Solid Tumors

Who this might be right for
Non-small Cell Lung CancerSolid Tumor
Sichuan Baili Pharmaceutical Co., Ltd. 20
Testing effectiveness (Phase 2)Ended earlyNCT05070247
What this trial is testing

TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Pancreatic CancerHepatocellular CancerMesothelioma+7 more
Takeda 61
Next Page